UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q/A
AMENDMENT NO. 1
X Quarterly report pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934. For the quarterly period
- -------- ended March 31, 1999.
- -------- Transition report pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934. For the transition period
from _____ to _____.
Commission File Number
0-27410
INTERCARDIA, INC.
-----------------
(Exact Name of Registrant as Specified in its Charter)
Delaware 56-1924222
-------- ----------
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification Number)
P.O. Box 14287
3200 East Highway 54
Cape Fear Building, Suite 300
Research Triangle Park, NC 27709
- --------------------------- ---------------------------
(Address of Principal Executive Office) (Zip Code)
Registrant's Telephone Number, Including Area Code 919-558-8688
---------------------------
Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or such shorter period that the registrant was required
to file such reports), and (2) has been subject to such filing requirements for
the past 90 days. YES [X] NO [ ]
Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of the latest practicable date.
Class Outstanding as of April 27, 1999
------------------ --------------------------------
Common Stock, par value $.001 7,341,503 Shares
<PAGE>
PART II. OTHER INFORMATION
Item 4. Submission of Matters to a Vote of Security Holders
The Annual Meeting of Stockholders of the Company was held on March 11,
1999. The following is a brief description of each matter voted upon at the
meeting and the number of affirmative votes and the number of negative votes
cast with respect to each matter.
(a) The stockholders elected the following persons as directors of the
Company: Glenn L. Cooper, M.D.; Clayton I. Duncan; Joseph J. Ruvane,
Jr.; David B. Sharrock; and Edgar H. Schollmaier. The votes for and
against (withheld) each nominee were as follows:
Votes Votes Votes
Nominee For Withheld Abstained
------- --- -------- ---------
Glenn L. Cooper, M.D. 6,877,572 43,489 0
Clayton I. Duncan 6,877,572 43,489 0
Joseph J. Ruvane, Jr. 6,877,572 43,489 0
David B. Sharrock 6,877,572 43,489 0
Edgar H. Schollmaier 6,877,572 43,489 0
(b) The stockholders approved an amendment to the Intercardia, Inc. 1995
Employee Stock Purchase Plan to increase the number of shares of Common
Stock reserved for issuance thereunder from 100,000 shares to 200,000
shares with 6,837,654 shares voting for, 71,554 shares voting against
and 3,280 shares abstained.
(c) The stockholders ratified the appointment of PricewaterhouseCoopers LLP
as the independent auditors of the Company for the fiscal year ending
September 30, 1999 with 6,919,237 shares voting for, 1,025 shares
voting against and 799 shares abstained.
2
<PAGE>
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
INTERCARDIA, INC.
Date: May 14, 1999 By: /s/ Richard W. Reichow
---------------------------------------------
Richard W. Reichow, Executive Vice President,
Chief Financial Officer and Treasurer
(Principal Financial and Accounting Officer)
3
